Oxford BioMedica (United Kingdom)

Oxford BioMedica (United Kingdom)

Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Oxford BioMedica (United Kingdom), United Kingdom, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

82%


Total
Publications

3.4K


Total Open
Publications

2.8K


Total
Citations

130K


Open Access
Percentage

82%


Total
Publications

3.4K


Total Open
Publications

2.8K


Total
Citations

130K

Wikipedia

Website

download

Breakdown

12% 51% 19% 18%

Publisher Open

12%

Both

51%

Other Platform Open

19%

Closed

18%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

050100150200250300350400450500Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

36%OA Journal

OA Journal 36%

765

Hybrid 40%

852

No Guarantees 24%

522

Other Platform Open

Institution 76%

1.8K

Domain 65%

1.5K

Preprint 14%

339

Other Internet 13%

301

Public 6%

151

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
1.5K
University of Oxford - Oxford University Research Archive (ORA)
Institution
1.2K
Europe PMC
Domain
717
University College London - UCL Discovery
Institution
444
DOI
Other Internet
235
University of Bristol - Bristol Research
Institution
205
University of Edinburgh - Edinburgh Research Explorer
Institution
193
University of Southampton - ePrints Soton
Institution
172
University of Cambridge - Apollo
Institution
167
bioRxiv
Preprint
147
1 / 20

Data updated 13 May 2024

Share

Share

Share